Detalhe da pesquisa
1.
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.
N Engl J Med
; 368(1): 34-44, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23281974
2.
Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial.
Lancet
; 381(9883): 2100-7, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23499440
3.
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial.
Lancet
; 376(9751): 1467-75, 2010 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20951424